Sign In
About ASHM | Careers | Your Cart Shoppint Cart
Skip Navigation LinksASHM Internet Home > ASHM Position Statements

ASHM Position Statements

This page provides links to policy and position statements written by ASHM on behalf of its members.

Members contribute to the development of these papers by making submissions or comment on documents being prepared by ASHM. ASHM may also make submissions on members' behalf and/or call meetings to discuss various issues.

Contribute to policy by becoming a member of ASHM.

Find out more about ASHM membership.


 

 

Position Statement: HIV Testinghttp://www.ashm.org.au/Pages/Media/Position-Statement-HIV-Testing.aspxPosition Statement: HIV TestingHIV testing is an essential as an access point to HIV care and to reduce the transmission of HIV. Testing in Australasia should be of the highest quality for the purpose for which it will be used. Access to testing should be as flexible as possible...GP0|#64a94011-4b4e-47fd-ba03-3a193247799a;L0|#064a94011-4b4e-47fd-ba03-3a193247799a|Position Statement;GTSet|#48fc36ff-f241-4a97-8906-dc332a2c106e;GPP|#c36cf865-d47b-4684-b5d0-cd345320e21bGP0|#43e42eb1-a069-43e4-baff-1bc89aeaeb11;L0|#043e42eb1-a069-43e4-baff-1bc89aeaeb11|ASHM;GTSet|#e2da4fc3-3bee-4dbc-83a4-35cc0aae5aa48/03/2017 1:00:00 PM
Position Statement Importation of Generic HCV Drugshttp://www.ashm.org.au/Pages/Media/Position-Statement-Importation-of-Generic-HCV-Drugs.aspxPosition Statement Importation of Generic HCV Drugs​ASHM supports unrestricted and universal access to DAA interferon free treatment regimens for those living with hepatitis C as a way to improve individual and public health outcomes. It is optimal for these drugs to be TGA approved...GP0|#64a94011-4b4e-47fd-ba03-3a193247799a;L0|#064a94011-4b4e-47fd-ba03-3a193247799a|Position Statement;GTSet|#48fc36ff-f241-4a97-8906-dc332a2c106e;GPP|#c36cf865-d47b-4684-b5d0-cd345320e21bGP0|#a1581b02-cca1-478b-9d26-5045f1b59502;L0|#0a1581b02-cca1-478b-9d26-5045f1b59502|Hepatitis C;GTSet|#dd3bb5ec-7f07-44a6-ad6a-353b82624b89GP0|#43e42eb1-a069-43e4-baff-1bc89aeaeb11;L0|#043e42eb1-a069-43e4-baff-1bc89aeaeb11|ASHM;GTSet|#e2da4fc3-3bee-4dbc-83a4-35cc0aae5aa48/03/2017 1:00:00 PM
ASHM supports trial of Medically Supervised Injection Facility in North Richmondhttp://www.ashm.org.au/Pages/Media/ASHM-supports-trial-of-Medically-Supervised-Injection-Facility-in-North-Richmond.aspxASHM supports trial of Medically Supervised Injection Facility in North RichmondAn Open Letter to the Victorian Parliament, published in the Herald Sun today, contains 48 signatories from key sectors of the Victorian community for a trial of a Medically Supervised Injection Facility in North Richmond.GP0|#5853b758-e9db-4416-ae45-7cf33269560a;L0|#05853b758-e9db-4416-ae45-7cf33269560a|Media Release;GTSet|#48fc36ff-f241-4a97-8906-dc332a2c106e;GPP|#c36cf865-d47b-4684-b5d0-cd345320e21b;GP0|#64a94011-4b4e-47fd-ba03-3a193247799a;L0|#064a94011-4b4e-47fd-ba03-3a193247799a|Position StatementGP0|#43e42eb1-a069-43e4-baff-1bc89aeaeb11;L0|#043e42eb1-a069-43e4-baff-1bc89aeaeb11|ASHM;GTSet|#e2da4fc3-3bee-4dbc-83a4-35cc0aae5aa47/02/2017 1:00:00 PM
ASHM endorses AMA Position Statement on BBVhttp://www.ashm.org.au/Pages/ASHM-endorses-AMA-Position-Statement-on-BBV.aspxASHM endorses AMA Position Statement on BBVThe AMA has released a welcome position statement on BBVs on 9 January 2017. Importantly it endorses NSP in prisons, the role of primary care in management of BBV, legal protection for sex workers, a recognition of key affected populations and HTLV-1.GP0|#64a94011-4b4e-47fd-ba03-3a193247799a;L0|#064a94011-4b4e-47fd-ba03-3a193247799a|Position Statement;GTSet|#48fc36ff-f241-4a97-8906-dc332a2c106e;GPP|#c36cf865-d47b-4684-b5d0-cd345320e21bGP0|#8ab7205f-9a3e-4243-b625-fa0c0db6a04c;L0|#08ab7205f-9a3e-4243-b625-fa0c0db6a04c|Hepatitis B;GTSet|#dd3bb5ec-7f07-44a6-ad6a-353b82624b89;GP0|#a1581b02-cca1-478b-9d26-5045f1b59502;L0|#0a1581b02-cca1-478b-9d26-5045f1b59502|Hepatitis CGP0|#43e42eb1-a069-43e4-baff-1bc89aeaeb11;L0|#043e42eb1-a069-43e4-baff-1bc89aeaeb11|ASHM;GTSet|#e2da4fc3-3bee-4dbc-83a4-35cc0aae5aa4;GP0|#f8fe9405-b889-4059-9d4f-604e788720e1;L0|#0f8fe9405-b889-4059-9d4f-604e788720e1|External Organisation22/01/2017 1:00:00 PM
Position Statement: Hepatitis C Prescribinghttp://www.ashm.org.au/Pages/Media/Position-Statement-Hepatitis-C-Prescribing.aspxPosition Statement: Hepatitis C PrescribingASHM believes that all clinicians with the skills and experience to manage hepatitis C should be able to initiate treatment. ASHM knows that clinicians gain skills and experience from a number of sources.GP0|#64a94011-4b4e-47fd-ba03-3a193247799a;L0|#064a94011-4b4e-47fd-ba03-3a193247799a|Position Statement;GTSet|#48fc36ff-f241-4a97-8906-dc332a2c106e;GPP|#c36cf865-d47b-4684-b5d0-cd345320e21bGP0|#f001df20-76bd-422b-9adc-dc3407467c1e;L0|#0f001df20-76bd-422b-9adc-dc3407467c1e|Co-infection;GTSet|#dd3bb5ec-7f07-44a6-ad6a-353b82624b89;GP0|#a1581b02-cca1-478b-9d26-5045f1b59502;L0|#0a1581b02-cca1-478b-9d26-5045f1b59502|Hepatitis CGP0|#43e42eb1-a069-43e4-baff-1bc89aeaeb11;L0|#043e42eb1-a069-43e4-baff-1bc89aeaeb11|ASHM;GTSet|#e2da4fc3-3bee-4dbc-83a4-35cc0aae5aa431/10/2016 1:00:00 PM
Position Statement: Nurse Practitioner Prescribing for Section 100 Medications for the treatment of HIV and Hepatitis B and Section 85 Medications for Hepatitis C in Australiahttp://www.ashm.org.au/Pages/Media/Position-Statement-Nurse-Practitioner-Prescribing-s100-s85-Medications.aspxPosition Statement: Nurse Practitioner Prescribing for Section 100 Medications for the treatment of HIV and Hepatitis B and Section 85 Medications for Hepatitis C in AustraliaASHM advocates for and supports a change to the PBS to allow suitably qualified Nurse Practitioners to be able to autonomously prescribe PBS subsidized treatments for blood borne viruses including HIV, hepatitis B and hepatitis C.GP0|#64a94011-4b4e-47fd-ba03-3a193247799a;L0|#064a94011-4b4e-47fd-ba03-3a193247799a|Position Statement;GTSet|#48fc36ff-f241-4a97-8906-dc332a2c106e;GPP|#c36cf865-d47b-4684-b5d0-cd345320e21bGP0|#8ab7205f-9a3e-4243-b625-fa0c0db6a04c;L0|#08ab7205f-9a3e-4243-b625-fa0c0db6a04c|Hepatitis B;GTSet|#dd3bb5ec-7f07-44a6-ad6a-353b82624b89;GP0|#a1581b02-cca1-478b-9d26-5045f1b59502;L0|#0a1581b02-cca1-478b-9d26-5045f1b59502|Hepatitis C;GP0|#dd9963c0-8c72-40e7-83e9-94fb06eb72f5;L0|#0dd9963c0-8c72-40e7-83e9-94fb06eb72f5|HIVGP0|#43e42eb1-a069-43e4-baff-1bc89aeaeb11;L0|#043e42eb1-a069-43e4-baff-1bc89aeaeb11|ASHM;GTSet|#e2da4fc3-3bee-4dbc-83a4-35cc0aae5aa418/10/2016 1:00:00 PM
Position Statement: HIV not transmitted via spittinghttp://www.ashm.org.au/Pages/Media/Position-Statement-HIV-not-transmitted-via-spitting.aspxPosition Statement: HIV not transmitted via spittingHIV isn't transmitted by spitting + there has been no case of transmission of HIV from having been spat upon. ASHM does not endorse or support HIV testing of an individual because they have been spat upon by a person with HIV/person of unknown HIV status.GP0|#64a94011-4b4e-47fd-ba03-3a193247799a;L0|#064a94011-4b4e-47fd-ba03-3a193247799a|Position Statement;GTSet|#48fc36ff-f241-4a97-8906-dc332a2c106e;GPP|#c36cf865-d47b-4684-b5d0-cd345320e21bGP0|#dd9963c0-8c72-40e7-83e9-94fb06eb72f5;L0|#0dd9963c0-8c72-40e7-83e9-94fb06eb72f5|HIV;GTSet|#dd3bb5ec-7f07-44a6-ad6a-353b82624b89GP0|#43e42eb1-a069-43e4-baff-1bc89aeaeb11;L0|#043e42eb1-a069-43e4-baff-1bc89aeaeb11|ASHM;GTSet|#e2da4fc3-3bee-4dbc-83a4-35cc0aae5aa417/10/2016 1:00:00 PM
Treatment Now Recommended for all people with HIVhttp://www.ashm.org.au/Pages/News/Treatment-recommended.aspxTreatment Now Recommended for all people with HIV Based on the results from two large trials, the Australasian Society for HIV Medicine (ASHM) Sub-Committee for Guidance on HIV Management in Australia strongly recommends that all people with HIV, regardless of their viral load or CD4 count, consider staGP0|#c36cf865-d47b-4684-b5d0-cd345320e21b;L0|#0c36cf865-d47b-4684-b5d0-cd345320e21b|News;GTSet|#48fc36ff-f241-4a97-8906-dc332a2c106e;GP0|#64a94011-4b4e-47fd-ba03-3a193247799a;L0|#064a94011-4b4e-47fd-ba03-3a193247799a|Position Statement;GPP|#c36cf865-d47b-4684-b5d0-cd345320e21b;GP0|#5853b758-e9db-4416-ae45-7cf33269560a;L0|#05853b758-e9db-4416-ae45-7cf33269560a|Media ReleaseGP0|#43e42eb1-a069-43e4-baff-1bc89aeaeb11;L0|#043e42eb1-a069-43e4-baff-1bc89aeaeb11|ASHM;GTSet|#e2da4fc3-3bee-4dbc-83a4-35cc0aae5aa413/09/2015 2:00:00 PM
START (Strategic Timing of Antiretroviral Treatment) http://www.ashm.org.au/when-to-start-antiretroviral-therapy-in-people-with-hivSTART (Strategic Timing of Antiretroviral Treatment) GP0|#64a94011-4b4e-47fd-ba03-3a193247799a;L0|#064a94011-4b4e-47fd-ba03-3a193247799a|Position Statement;GTSet|#48fc36ff-f241-4a97-8906-dc332a2c106e;GPP|#c36cf865-d47b-4684-b5d0-cd345320e21bGP0|#dd9963c0-8c72-40e7-83e9-94fb06eb72f5;L0|#0dd9963c0-8c72-40e7-83e9-94fb06eb72f5|HIV;GTSet|#dd3bb5ec-7f07-44a6-ad6a-353b82624b89GP0|#43e42eb1-a069-43e4-baff-1bc89aeaeb11;L0|#043e42eb1-a069-43e4-baff-1bc89aeaeb11|ASHM;GTSet|#e2da4fc3-3bee-4dbc-83a4-35cc0aae5aa424/06/2015 2:00:00 PM
HIV Point of Care Tests/Testing (PoCT)http://www.ashm.org.au/Pages/Media/Position-Statement-HIV-PoCT.aspxHIV Point of Care Tests/Testing (PoCT)ASHM believes that PoCT is a valuable tool with the potential to play an important part in Australia's response to HIV by increasing the number of high risk individuals who will be screened.GP0|#64a94011-4b4e-47fd-ba03-3a193247799a;L0|#064a94011-4b4e-47fd-ba03-3a193247799a|Position Statement;GTSet|#48fc36ff-f241-4a97-8906-dc332a2c106e;GPP|#c36cf865-d47b-4684-b5d0-cd345320e21bGP0|#dd9963c0-8c72-40e7-83e9-94fb06eb72f5;L0|#0dd9963c0-8c72-40e7-83e9-94fb06eb72f5|HIV;GTSet|#dd3bb5ec-7f07-44a6-ad6a-353b82624b89GP0|#43e42eb1-a069-43e4-baff-1bc89aeaeb11;L0|#043e42eb1-a069-43e4-baff-1bc89aeaeb11|ASHM;GTSet|#e2da4fc3-3bee-4dbc-83a4-35cc0aae5aa424/07/2013 2:00:00 PM

Please enter a valid E-mail.
This must match your colleagues E-mail.
Please enter your name.
Please enter a valid email.
This must match your email.